Mutations in K-ras Codon 12 Detected in Plasma DNA Are Not an Indicator of Disease in Patients with Non-Small Cell Lung Cancer

This publication has 13 references indexed in Scilit:

• Inhaled particles and lung cancer. Part A: Mechanisms
  International Journal of Cancer, 2004
• Preferential Isolation of Fragmented DNA Enhances the Detection of Circulating Mutated k-ras DNA
  Clinical Chemistry, 2004
• Comment on "Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-call lung cancer patients" (Cancer Letters 2003;193:207-216).
  Cancer Letters, 2003
• The Potential Contributions of Chronic Inflammation to Lung Carcinogenesis
  Clinical Lung Cancer, 2003
• Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients
  Cancer Letters, 2003
• Topographic analysis of K-ras mutations in histologically normal lung tissues and tumours of lung cancer patients
  British Journal of Cancer, 2001
• Somatic Mutation Screening: Identification of Individuals Harboring K-ras Mutations With the Use of Plasma DNA
  JNCI Journal of the National Cancer Institute, 2000
• K‐rasgene point mutation in neogenetic lesions of subpleural fibrotic lesions: Either an early genetic event in lung cancer development or a non‐specific genetic change during the inflammatory reparative process
  Pathology International, 1999
• Stimulated human leukocytes cause activating mutations in the K-ras proto-oncogene
  Oncogene, 1997
• Excretion of Deoxyribonucleic Acid by Lymphocytes Stimulated with Phytohemagglutinin or Antigen
  Proceedings of the National Academy of Sciences, 1972